Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
COURT REPORT: U.S. Veterans sue Veterans United Home Loans; Zillow and Redfin push back against FTC suit

COURT REPORT: U.S. Veterans sue Veterans United Home Loans; Zillow and Redfin push back against FTC suit

Neutral RIS Media - Connecticut
Owner: John E. Featherson
U.S. Rep. Vasquez ‘fully’ supports N.M. Legislature’s ban on ICE detention facilities

U.S. Rep. Vasquez ‘fully’ supports N.M. Legislature’s ban on ICE detention facilities

U.S. Citizens Reject Blockade Against Cuba as Exxon Mobil Appears Before Court

U.S. Citizens Reject Blockade Against Cuba as Exxon Mobil Appears Before Court

U.S. Rep. Vasquez ‘fully’ supports NM Legislature’s ban on ICE detention facilities

U.S. Rep. Vasquez ‘fully’ supports NM Legislature’s ban on ICE detention facilities

U.S. Marine Corps Expands MQ-9A Reaper Drones Under Aviation Plan 2026 for Indo-Pacific

U.S. Marine Corps Expands MQ-9A Reaper Drones Under Aviation Plan 2026 for Indo-Pacific

U.S. Air Force Pairs F-22 Fighter With MQ-20 Drone in Live Manned-Unmanned Combat Drill

U.S. Air Force Pairs F-22 Fighter With MQ-20 Drone in Live Manned-Unmanned Combat Drill

U.S. Sen. Baldwin: Leads call for watchdog investigation of Trump’s efforts to dismantle education department

U.S. Sen. Baldwin: Leads call for watchdog investigation of Trump’s efforts to dismantle education department

U.S. FDA has granted accelerated approval of Loargys® (pegzilarginase-nbln) for the treatment of hyperargininemia in patients 2 years and older with Arginase 1 Deficiency (ARG1-D)

U.S. FDA has granted accelerated approval of Loargys® (pegzilarginase-nbln) for the treatment of hyperargininemia in patients 2 years and older with Arginase 1 Deficiency (ARG1-D)

U.S. weather and climate disasters could top $1 trillion by 2030

U.S. weather and climate disasters could top $1 trillion by 2030

U.S. Army Prepares AH-64E Apache Forces for Arctic Deep Attack Operations in Extreme Subzero Cond...

U.S. Army Prepares AH-64E Apache Forces for Arctic Deep Attack Operations in Extreme Subzero Cond...

Women's Health Company Mira Calls for Federal Reform of U.S. Sex Education

Women's Health Company Mira Calls for Federal Reform of U.S. Sex Education

AAR Hosts Collaborative Workforce Development discussion, Shares Insights with U.S. Deputy Secretary of Labor

AAR Hosts Collaborative Workforce Development discussion, Shares Insights with U.S. Deputy Secretary of Labor

Neutral Aviation Maintenance Magazine
Owner: Adrian Broadbent
U.S. Rep. Vasquez ‘fully’ supports N.M. Legislature’s ban on ICE detention facilities

U.S. Rep. Vasquez ‘fully’ supports N.M. Legislature’s ban on ICE detention facilities

U.S. Citizens Reject Blockade Against Cuba as Exxon Mobil Appears Before Court

U.S. Citizens Reject Blockade Against Cuba as Exxon Mobil Appears Before Court

U.S. Rep. Vasquez ‘fully’ supports NM Legislature’s ban on ICE detention facilities

U.S. Rep. Vasquez ‘fully’ supports NM Legislature’s ban on ICE detention facilities

U.S. Marine Corps Expands MQ-9A Reaper Drones Under Aviation Plan 2026 for Indo-Pacific

U.S. Marine Corps Expands MQ-9A Reaper Drones Under Aviation Plan 2026 for Indo-Pacific

U.S. Air Force Pairs F-22 Fighter With MQ-20 Drone in Live Manned-Unmanned Combat Drill

U.S. Air Force Pairs F-22 Fighter With MQ-20 Drone in Live Manned-Unmanned Combat Drill

U.S. Sen. Baldwin: Leads call for watchdog investigation of Trump’s efforts to dismantle education department

U.S. Sen. Baldwin: Leads call for watchdog investigation of Trump’s efforts to dismantle education department

U.S. FDA has granted accelerated approval of Loargys® (pegzilarginase-nbln) for the treatment of hyperargininemia in patients 2 years and older with Arginase 1 Deficiency (ARG1-D)

U.S. FDA has granted accelerated approval of Loargys® (pegzilarginase-nbln) for the treatment of hyperargininemia in patients 2 years and older with Arginase 1 Deficiency (ARG1-D)

U.S. weather and climate disasters could top $1 trillion by 2030

U.S. weather and climate disasters could top $1 trillion by 2030

U.S. Army Prepares AH-64E Apache Forces for Arctic Deep Attack Operations in Extreme Subzero Cond...

U.S. Army Prepares AH-64E Apache Forces for Arctic Deep Attack Operations in Extreme Subzero Cond...

Women's Health Company Mira Calls for Federal Reform of U.S. Sex Education

Women's Health Company Mira Calls for Federal Reform of U.S. Sex Education

COURT REPORT: U.S. Veterans sue Veterans United Home Loans; Zillow and Redfin push back against FTC suit

COURT REPORT: U.S. Veterans sue Veterans United Home Loans; Zillow and Redfin push back against FTC suit

Show More

Video Stories

YouTube video thumbnail: U.S. Beefing Up Firepower in Middle East as Trump Grows Impatient With Iran
Play
U.S. Beefing Up Firepower in Middle East as Trump Grows Impatient With Iran
YouTube video thumbnail: What's Next for Trade as Trump Ups Global Tariff to 15%
Play
What's Next for Trade as Trump Ups Global Tariff to 15%
YouTube video thumbnail: Greenland's PM Says 'No Thanks' to Trump's Hospital Ship
Play
Greenland's PM Says 'No Thanks' to Trump's Hospital Ship
YouTube video thumbnail: Mar-a-Lago Shooting: How Political Polarization Fuels Lone‑Actor Violence
Play
Mar-a-Lago Shooting: How Political Polarization Fuels Lone‑Actor Violence

Video Title

Press Releases

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions